Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

07.01.18	New Drugs Approved In December (RTTNews)
04.01.18	Berkeley Lights Announces Research Collaboration and License Agreement with Pfizer (PR Newswire)
04.01.18	Arvinas Sees $830 Mln Upfront, Potential Milestone Payments In Deal With Pfizer (RTTNews)
04.01.18	Arvinas Announces Research Collaboration and License Agreement with Pfizer Inc. for the Discovery and Development of Protein Degradation Drug Candidates (PR Newswire)
03.01.18	Sangamo, Pfizer Collaborate On Zinc Finger Protein Gene Therapy For ALS (RTTNews)
03.01.18	Sangamo and Pfizer announce collaboration for development of zinc finger protein gene therapy for ALS (PR Newswire)
27.12.17	Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference (Businesswire)
24.12.17	It's Raining FDA Approvals, SMMT Opens Wallet, AGRX Snubbed Yet Again (RTTNews)
22.12.17	Merck, Pfizer: FDA Approves Steglatro And Fixed-dose Combination Steglujan (RTTNews)
21.12.17	FDA Grants Breakthrough Therapy Designation for Avelumab in Combination with INLYTA® in Advanced Renal Cell Carcinoma (PR Newswire)
21.12.17	Pfizer Inc. Announces Pricing and Early Results of its Tender Offer for its 5.750 per cent. Notes due 2021 and Related Solicitation of Consents (Businesswire)
20.12.17	EXEL, PFE, ONCE Get FDA Nod, FPRX, ZLAB Team Up, SKLN Soars After Hours (RTTNews)
19.12.17	U.S. FDA Approves Pfizer’s BOSULIF® (bosutinib) for the Treatment of Patients with Newly-Diagnosed Ph+ Chronic Myelogenous Leukemia (CML) (Businesswire)
19.12.17	Pfizer Invites Public to View and Listen to Webcast of January 30 Conference Call with Analysts (Businesswire)
19.12.17	Array BioPharma Enters Into Clinical Trial Collaboration Agreement With Pfizer (RTTNews)
19.12.17	Pfizer Board Approves New $10 Bln Share Buy-back; Hikes Dividend (RTTNews)
18.12.17	Pfizer Declares First-Quarter 2018 Dividend (Businesswire)
15.12.17	Pfizer Inc. Announces Expiration and Results of its Private Exchange Offer for its 6.500 per cent. Notes due 2038 and Related Tender Offer (Businesswire)
15.12.17	Pfizer Says FDA Okays XELJANZ And XELJANZ XR To Treat Active Psoriatic Arthritis (RTTNews)
15.12.17	Pfizer Announces FDA Approval of XELJANZ® (tofacitinib) and XELJANZ® XR for the Treatment of Active Psoriatic Arthritis (Businesswire)
14.12.17	Pfizer Inc. Announces Pricing Terms of Private Exchange Offer for its 6.500 per cent. Notes due 2038 Open to Certain Investors and Related Tender Offer Open to All Investors (Businesswire)
14.12.17	Pfizer Initiates Phase 3 Program For PF-04965842 - Quick Facts (RTTNews)
14.12.17	Pfizer Initiates Phase 3 Program for PF-04965842, a JAK1 Inhibitor in Development for Moderate-to-Severe Atopic Dermatitis (Businesswire)
14.12.17	Pfizer Biosimilar Medicine IXIFI Gets FDA Approval For All Eligible Indications (RTTNews)
14.12.17	FDA Approves New Pfizer Biosimilar (Businesswire)
13.12.17	Phase 3 TRUMENBA® (Meningococcal Group B Vaccine) Data Published in New England Journal of Medicine Demonstrate the Vaccine’s Immunogenicity (Businesswire)
13.12.17	ADRO Dumps CRS-207, Another Win For CoolSculpting, FDA Expands GSK's Nucala Use (RTTNews)
12.12.17	U.S. Food And Drug Administration Extends Action Date For XELJANZ® (Tofacitinib) Supplemental New Drug Application In Ulcerative Colitis By Three Months (Businesswire)
12.12.17	Myriad: BRACAnalysis Cdx Test Identified Patients Who Responded To Talazoparib (RTTNews)
11.12.17	Spark, Pfizer Record Sustained Factor IX Activity Levels In SPK-9001 Trial (RTTNews)
08.12.17	Pfizer: Talazoparib Extends Progression-Free Survival In Phase 3 Trial (RTTNews)
08.12.17	Talazoparib Significantly Extends Progression-Free Survival in Phase 3 EMBRACA Trial of Patients with Metastatic Breast Cancer (Businesswire)
06.12.17	Updated Data from Phase 3 Trial of IBRANCE® (palbociclib) Plus Letrozole in ER+, HER2- Metastatic Breast Cancer Confirm Improvement in Progression-Free Survival (Businesswire)
05.12.17	Bristol-Myers Squibb and Pfizer Alliance Urge People to ‘Tune in to AFib, Take Note of Stroke Risk’ (Businesswire)
04.12.17	BioNews Capsule: Ready-to-drink Colonoscopy Prep, Viagra Connect, ZYNE's STARS (RTTNews)
01.12.17	Basilea Pharma Extends License Agreement For Cresemba To China, Asia Pacific (RTTNews)
01.12.17	Pfizer Enters into Agreement to Develop and Commercialize CRESEMBA® (isavuconazole) in China and Asia Pacific Region (Businesswire)
29.11.17	Biotech Stocks Facing FDA Decision In December (RTTNews)
29.11.17	EARS Pinched By HEALOS Data, EGLT Does It Again, JAVELIN Gastric 300 Misses Mark (RTTNews)
28.11.17	Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 300 Study in Patients With Pre-Treated Advanced Gastric Cancer (PR Newswire)
28.11.17	Merck, Pfizer: Phase III Javelin Gastric 300 Trial Did Not Meet Primary Endpoint (RTTNews)
22.11.17	ViiV Healthcare : FDA Okays First Two-drug Regimen For Certain Patients With HIV (RTTNews)
22.11.17	Juluca® (dolutegravir and rilpivirine) approved in US as first 2-drug regimen, once-daily, single pill - a complete regimen for the maintenance treatment of virologically suppressed HIV-1 infection (PR Newswire)
17.11.17	FDA Nod For Label Expansion Of Sutent, Egalet Flies, Double Blessing For Roche (RTTNews)
17.11.17	Pfizer: FDA Expands Approval Of Sutent To Reduce Risk Of Kidney Cancer Returning (RTTNews)
16.11.17	Pfizer Receives FDA Approval for SUTENT® (sunitinib malate) as First and Only Adjuvant Treatment for Adult Patients at High Risk of Recurrent Renal Cell Carcinoma (Businesswire)
13.11.17	Minister Chagger celebrates Global Entrepreneurship Week 2017 (PR Newswire)
13.11.17	Pfizer Appoints Albert Bourla As COO (RTTNews)
13.11.17	Pfizer Names Albert Bourla Chief Operating Officer (Businesswire)
10.11.17	BMS-Pfizer Alliance to Unveil Real-World Data Analyses - Cost, Safety and Comparative Effectiveness Findings Associated with Oral Anticoagulants in Non-Valvular Atrial Fibrillation (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Nestle	87.68	0.39 %	K V
Geberit	589.60	0.37 %	K V
Lonza Grp	600.00	0.33 %	K V
Holcim	93.80	0.28 %	K V
Swisscom	547.00	0.27 %	K V
Sonova Hldg	256.90	-0.19 %	K V
Sika	207.10	-0.53 %	K V
ABB	45.12	-0.59 %	K V
Alcon	80.20	-0.59 %	K V
Kuehne+Nagel Int	189.25	-1.41 %	K V

mehr

09:33		Roche-Aktie unbeeindruckt: Roche bringt neuen Test zur präziseren Leberfibrose-Diagnose auf den Markt
09:20		EVOTEC-Aktie rutscht ab: Operatives Ergebnis mehr als halbiert
05.05.25		SMI-Papier Novartis-Aktie: So viel Gewinn hätte ein Investment in Novartis von vor 10 Jahren abgeworfen
05.05.25		DAX 40-Papier Merck-Aktie: So viel Verlust hätte eine Merck-Investition von vor einem Jahr eingebracht
05.05.25		Novartis-Aktie: Das sind die Expertenmeinungen des Monats April
02.05.25		Stoxx Europe 50-Papier Sanofi-Aktie: Mit dieser Dividende bereitet Sanofi Aktionären eine Freude
02.05.25		Deutsche Bank AG veröffentlicht Investment-Empfehlung: Merck-Aktie mit Buy
02.05.25		Aktien-Analyse: Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) bewertet Novartis-Aktie

09:33

Roche-Aktie unbeeindruckt: Roche bringt neuen Test zur präziseren Leberfibrose-Diagnose auf den Markt

09:20

EVOTEC-Aktie rutscht ab: Operatives Ergebnis mehr als halbiert

05.05.25

SMI-Papier Novartis-Aktie: So viel Gewinn hätte ein Investment in Novartis von vor 10 Jahren abgeworfen

05.05.25

DAX 40-Papier Merck-Aktie: So viel Verlust hätte eine Merck-Investition von vor einem Jahr eingebracht

05.05.25

Novartis-Aktie: Das sind die Expertenmeinungen des Monats April

02.05.25

Stoxx Europe 50-Papier Sanofi-Aktie: Mit dieser Dividende bereitet Sanofi Aktionären eine Freude